Federal prosecutors have served Gilead Sciences with a subpoena for documents related to marketing of HIV meds Emtriva (emtricitabine), Viread (tenofovir) and Truvada (a combination of the other two). The U.S. attorney’s office may be increasing its focus on allegations that some drug companies promote products for uses not approved by the FDA, according to one report.